AV

Avalyn Pharma Inc

NASDAQ: AVLN

6 known investors

avalynpharma.com ↗

Avalyn Pharma develops a nebulized inhalation treatment for pulmonary fibrosis designed to improve tolerability compared to existing oral therapies by directly delivering the drug to the lungs.

Founders & leadership

LB

Lyn BaranowskiinCEO

Investors · 6

AN

Andera PartnersParis

F-

F-Prime Capital PartnersCambridge · $3M – $10M

IN

InVivium CapitalChicago

NO

Norwest Venture PartnersMenlo Park · $10M – $30M

RI

RiverVest Venture PartnersSt. Louis · $500K – $3M

VI

Vida VenturesLos Angeles